---
title: "ANKE BIO: Net profit in the first half of 2025 is 367 million yuan, a year-on-year decrease of 11.92%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253971285.md"
description: "ANKE BIO announced that its operating revenue in the first half of 2025 was 1.292 billion yuan, a year-on-year decrease of 0.51%. Net profit was 367 million yuan, a year-on-year decrease of 11.92%"
datetime: "2025-08-21T10:55:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253971285.md)
  - [en](https://longbridge.com/en/news/253971285.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253971285.md)
generator: "portal-rs"
---

# ANKE BIO: Net profit in the first half of 2025 is 367 million yuan, a year-on-year decrease of 11.92%

ANKE BIO announced that its operating revenue in the first half of 2025 was 1.292 billion yuan, a year-on-year decrease of 0.51%. The net profit was 367 million yuan, a year-on-year decrease of 11.92%

### Related Stocks

- [300009.CN](https://longbridge.com/en/quote/300009.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [Rapala VMC: Strong H1 sales and profit growth led to upgraded full-year outlook amid ongoing trade risks](https://longbridge.com/en/news/296480810.md)
- [DIMRI: H1 2026 net profit rose to ₪495.6M on revenue of ₪780.5M, with robust liquidity and equity](https://longbridge.com/en/news/296448412.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**